Silva Pharmaceuticals Limited

DSE:SILVAPHL Stock Report

Market Cap: ৳1.4b

Silva Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Saira Khan

Chief executive officer

৳1.2m

Total compensation

CEO salary percentagen/a
CEO tenure7.9yrs
CEO ownership5.4%
Management average tenureno data
Board average tenure7.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Saira Khan's remuneration changed compared to Silva Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-৳90m

Jun 30 2024৳1mn/a

-৳64m

Mar 31 2024n/an/a

-৳31m

Dec 31 2023n/an/a

-৳28m

Sep 30 2023n/an/a

-৳338k

Jun 30 2023৳1mn/a

৳33m

Mar 31 2023n/an/a

৳57m

Dec 31 2022n/an/a

৳78m

Sep 30 2022n/an/a

৳89m

Jun 30 2022৳1mn/a

৳102m

Mar 31 2022n/an/a

৳119m

Dec 31 2021n/an/a

৳115m

Sep 30 2021n/an/a

৳112m

Jun 30 2021৳1mn/a

৳120m

Mar 31 2021n/an/a

৳116m

Dec 31 2020n/an/a

৳118m

Sep 30 2020n/an/a

৳126m

Jun 30 2020৳1mn/a

৳119m

Mar 31 2020n/an/a

৳126m

Dec 31 2019n/an/a

৳133m

Sep 30 2019n/an/a

৳131m

Jun 30 2019৳43kn/a

৳143m

Mar 31 2019n/an/a

৳136m

Dec 31 2018n/an/a

৳125m

Sep 30 2018n/an/a

৳123m

Jun 30 2018৳1m৳1m

৳93m

Compensation vs Market: Saira's total compensation ($USD10.31K) is below average for companies of similar size in the BD market ($USD22.00K).

Compensation vs Earnings: Saira's compensation has increased whilst the company is unprofitable.

CEO

Saira Khan (43 yo)

7.9yrs

Tenure

৳1,237,500

Compensation

Dr. Saira Khan MBBS, DCH, FCPS, serves as Managing Director, Chief Executive Officers at Silva Pharmaceuticals Limited since 2017 and has been its Director since 2017.

Board Members

NamePositionTenureCompensationOwnership
Saira Khan
MD, CEO & Director7.9yrs৳1.24m5.36%
BDT 75.4m
Mahmuda Akhter
Nominee Director3.8yrs৳37.50kno data
Silvana Mirza
Chairman of the Board23.9yrs৳37.50k12.85%
BDT 180.7m
Samina Mirza
Director23.9yrs৳75.00k2.24%
BDT 31.5m
Farhana Mirza
Director23.9yrs৳28.13k2.24%
BDT 31.5m
Monsur Rahman
Nominee Director7.9yrs৳84.38k3.92%
BDT 55.0m
Muhammad Moniruzzaman
Independent Director4.8yrs৳46.88kno data
A. T. M. Sarrowar Chowdhury
Independent Director1.4yrs৳75.00kno data

7.9yrs

Average Tenure

44yo

Average Age

Experienced Board: SILVAPHL's board of directors are considered experienced (7.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 03:17
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Silva Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution